Adherence Monitoring For Substance Abuse Clinical Trials

The purpose of this study is to determine the feasibility and accuracy of an automated adherence monitoring system, and to compare the variance between urine and oral fluid riboflavin levels when specimens are obtained 'as usual' and after a one-hour inter specimen interval.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Medication Adherence Behavior Health Behavior Patient Acceptance of Health Care Patient Compliance Treatment Adherence and Compliance

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Addiction & Pharmacology Research Lab, St. Luke's Hospital

San Francisco, California, 94110, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Male or female, aged 18 to 60
Ability to give informed consent.
Be willing and able to use the study-provided phone for taking and transmitting capsule photos.

Exclusion criteria

Unwilling or unable to use a cell phone.
Any medical, psychiatric, or other condition that, in the opinion of the investigator, would preclude safe, consistent, or useful participation in the study.

Treatment and study plan

Automated Adherence Monitoring System

Other

Primary outcomes

Variance between urine and oral fluid riboflavin levels when specimens are obtained 'as usual' and after a one-hour inter specimen interval

Time frame: + 1, 2, 3, 4, 6 hours post dose

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

California Pacific Medical Center Research Institute

Other

Collaborators

Creare, Inc.

Registry information

Important dates

Study start: 2013
Primary completion: 2013
Study completion: 2013
First posted: Jun 4, 2013
Registry last updated: Jun 4, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed